Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
7,420.00    35.00 (0.47%)
Bid:
7,425.00
Ask:
7,430.00
Spread: 5.00 (0.067%)
Market Cap: £32.85b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Directorate Change

14 Dec 2023 11:00

RNS Number : 8350W
Coca-Cola Europacific Partners plc
14 December 2023
Β 

COCA-COLA EUROPACIFIC PARTNERS PLC

Β 

BOARD AND COMMITTEE CHANGES

Β 

Coca-Cola Europacific Partners plc (CCEP) announces that Garry Watts has resigned from the Board with effect from 31 December 2023. As part of the Board's succession planning and following a comprehensive search and selection process, the Board has approved the appointment of Guillaume Bacuvier as a new Independent Non-executive Director to succeed Garry, which was approved by the Board on 13 December 2023. Guillaume's appointment will be effective from 1 January 2024.

Β 

Garry Watts was appointed as a Non-executive Director of CCEP in April 2016, having previously been a director of Coca-Cola Enterprises Inc ("CCE") since 2010. He served as Chairman of the Audit Committee from April 2016 until May 2022 and has remained a member of the Committee to date. Garry was previously a member of the Remuneration Committee from April 2016 until October 2021 and has also been a member of the Affiliated Transaction Committee since October 2021. His extensive financial and business experience in Western Europe and particularly the UK has been invaluable to the Board since the merger. The Board would also like to recognise the contribution Garry has played in shaping the success of CCEP to date.

Β 

As part of the changes, effective 1 January 2024 Nicolas Mirzayantz will become a member of the Audit Committee.

Β 

About Guillaume Bacuvier

Β 

Guillaume Bacuvier brings to the Board valuable perspectives on consumer behaviors and strategy, as well as marketing effectiveness insights from across Europe and APAC obtained through his consulting work. Guillaume is currently the CEO of Worldpanel, Kantar's consumer panel market research division, where he is leading the transformation of the company's operating model and technology environment. He also serves as a Non-executive Director of Berger-Levrault a mid-cap software business. Guillaume was previously the CEO of Dunnhumby and held a number of senior positions at Google and Orange, as well as Non-executive directorships with Attest and VEON.

Β Β 

SolΒ Daurella, Chairman said, "Garry has made a huge contribution from the very beginning of CCEP and has been instrumental in our success. We wish him every success for the future. I would also like to welcome Guillaume to the Board and I look forward to working with him and the rest of the Board."

Β 

This announcement is made pursuant to LR 9.6.11R of the Listing Rules.

Β 

There is no further information required to be notified under Listing Rule 9.6.13R with regard to Guillaume Bacuvier's appointment referred to above.Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

CONTACTS

Β 

Company Secretariat

Clare Wardle

T +44 20 7355 8406

Investor Relations

Sarah Willett

+44 7970 145 218

Media Relations

Shanna Wendt

T +44 7976 595 168

Β 

ABOUT CCEP

Β 

CCEP is one of the leading consumer goods companies in the world. We make, move and sell some the world's most loved brands - serving 600 million consumers and helping 2 million customers across 30 countries grow their business. We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support. The Company is currently listed on Euronext Amsterdam, the NASDAQ Global Select Market, London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP. For more information about CCEP, please visit www.cocacolaep.com & follow CCEP on Twitter at @CocaColaEP.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAFIFSAFLLSLIV
Date   Source Headline
12th Jun 20264:30 pmRNSDirector/PDMR Shareholding
5th Jun 20263:30 pmRNSDirector/PDMR Shareholding
3rd Jun 202612:30 pmRNSDirector/PDMR Shareholding
1st Jun 20261:30 pmRNSTotal Voting Rights
29th May 20261:00 pmRNSResult of AGM
21st May 20263:30 pmRNSDirector/PDMR Shareholding
18th May 202611:00 amRNSLetter to Shareholders
1st May 20264:15 pmRNSDirector/PDMR Shareholding
1st May 20261:30 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSQ1 Trading Update & Interim Dividend Declaration
27th Apr 20263:00 pmRNSTransactions in Own Shares
22nd Apr 20262:15 pmRNSDirector/PDMR Shareholding
20th Apr 20261:30 pmRNSTransactions in Own Shares
16th Apr 20269:15 amRNSNotice of AGM
15th Apr 202610:30 amRNSDirector/PDMR Shareholding
13th Apr 202612:30 pmRNSTransaction in Own Shares
10th Apr 202611:00 amRNSSID Appointment and Board Committee Changes
7th Apr 20262:00 pmRNSTransaction in Own Shares
1st Apr 20262:30 pmRNSTotal Voting Rights
1st Apr 202611:00 amRNSChange of Company Secretary
30th Mar 20263:30 pmRNSTransactions in Own Shares
27th Mar 20269:00 amRNSDirector/PDMR Shareholding
24th Mar 202612:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransactions in Own Shares
20th Mar 20264:45 pmRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransactions in Own Shares
19th Mar 20267:00 amRNSTransactions in Own Shares
18th Mar 20267:00 amRNSTransactions in Own Shares
17th Mar 20267:00 amRNSTransactions in Own Shares
17th Mar 20267:00 amRNSTransactions in Own Shares
16th Mar 20265:00 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransactions in Own Shares
16th Mar 20267:00 amRNSTransactions in Own Shares
13th Mar 202612:11 pmRNSAnnual Financial Report
13th Mar 202612:11 pmRNSAnnual Financial Report
13th Mar 20267:00 amRNSTransactions in Own Shares
13th Mar 20267:00 amRNSTransactions in Own Shares
12th Mar 20267:00 amRNSTransactions in Own Shares
12th Mar 20267:00 amRNSTransactions in Own Shares
11th Mar 20267:00 amRNSTransactions in Own Shares
10th Mar 20267:00 amRNSTransactions in Own Shares
9th Mar 20267:00 amRNSTransactions in Own Shares
6th Mar 20267:00 amRNSTransactions in Own Shares
5th Mar 20267:00 amRNSTransactions in Own Shares
4th Mar 20264:00 pmRNSDirectorate change
4th Mar 20267:00 amRNSTransactions in Own Shares
3rd Mar 20265:13 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:00 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSTransactions in Own Shares
2nd Mar 20261:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.